Contact
 

Timely Topics in HIV Vaccines: VISP Meeting Report

The Enterprise and partners held a consultation on 14 - 15 March 2013 around the issue of VISP/R.  The full meeting report is available to download below.

Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account